REFERENCES
1. Gilhar A, Ullmann Y, Karry R, et al. Ageing of human epidermis: the role of apoptosis, Fas and telomerase. Br J Dermatol 2004;150:56-63.
2. Varani J, Dame MK, Rittie L, et al. Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am J Pathol 2006;168:1861-8.
3. Suwabe H, Serizawa A, Kajiwara H, Ohkido M, Tsutsumi Y. Degenerative processes of elastic fibers in sun-protected and sun-exposed skin: immunoelectron microscopic observation of elastin, fibrillin-1, amyloid P component, lysozyme and alpha1-antitrypsin. Pathol Int 1999;49:391-402.
4. Gierloff M, Stöhring C, Buder T, Gassling V, Açil Y, Wiltfang J. Aging changes of the midfacial fat compartments: a computed tomographic study. Plast Reconstr Surg 2012;129:263-73.
5. Boehm LM, Morgan A, Hettinger P, Matloub HS. Facial aging: a quantitative analysis of midface volume changes over 11 years. Plast Reconstr Surg 2021;147:319-27.
6. Tower J, Seifert K, Paskhover B. Longitudinal analysis of superficial midfacial fat volumes over a 10-year period. Aesthetic Plast Surg 2018;42:995-1001.
7. Rohrich RJ, Avashia YJ, Savetsky IL. Prediction of facial aging using the facial fat compartments. Plast Reconstr Surg 2021;147:38S-42S.
8. Owsley JQ Jr, Zweifler M. Midface lift of the malar fat pad: technical advances. Plast Reconstr Surg 2002;110:674-85; discussion 686-7.
9. De Cordier BC, de la Torre JI, Al-Hakeem MS, et al. Rejuvenation of the midface by elevating the malar fat pad: review of technique, cases, and complications. Plast Reconstr Surg 2002;110:1526-36; discussion 1537-40.
10. Barrett DM, Gerecci D, Wang TD. Facelift controversies. Facial Plast Surg Clin North Am 2016;24:357-66.
12. Abraham RF, DeFatta RJ, Williams EF 3rd. Thread-lift for facial rejuvenation: assessment of long-term results. Arch Facial Plast Surg 2009;11:178-83.
14. Tonnard P, Verpaele A, Monstrey S, et al. Minimal access cranial suspension lift: a modified S-lift. Plast Reconstr Surg 2002;109:2074-86.
15. Chang S, Pusic A, Rohrich RJ. A systematic review of comparison of efficacy and complication rates among face-lift techniques. Plast Reconstr Surg 2011;127:423-33.
16. Kim BJ, Choi JH, Lee Y. Development of facial rejuvenation procedures: thirty years of clinical experience with face lifts. Arch Plast Surg 2015;42:521-31.
17. General and Plastic Surgery Devices. FDA executive summary general issues panel meeting on dermal fillers. Available from: https://www.fda.gov/media/146870/download. [Last accessed on 2 Aug 2021].
18. Petchngaovilai C. Midface lifting with botulinum toxin: intradermal technique. J Cosmet Dermatol 2009;8:312-6.
19. Chang SP, Tsai HH, Chen WY, Lee WR, Chen PL, Tsai TH. The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A. Int J Dermatol 2008;47:1287-94.
20. Kimura K, Tanaka Y. Facial tightening effects, following focused and radial acoustic wave therapy assessment, using a three-dimensional digital imaging. Lasers Surg Med 2021;53:630-9.
21. Sasaki GH. Early clinical experience with the 1440-nm wavelength internal pulsed laser in facial rejuvenation: two-year follow-up. Clin Plast Surg 2012;39:409-17.
22. Kwon HH, Choi SC, Park KH, Jung JY. A novel combination regimen with intense focused ultrasound and pressure- and dose-controlled transcutaneous pneumatic injection of hypertonic glucose solution for lifting and tightening of the aging face. J Cosmet Dermatol 2018;17:373-9.
23. Ozgentaş HE, Pindur A, Spira M, Liu B, Shenaq S. A comparison of soft-tissue substitutes. Ann Plast Surg 1994;33:171-7.
24. Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: a key molecule in skin aging. Dermatoendocrinol 2012;4:253-8.
25. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004;4:528-39.
26. Meyer LJ, Stern R. Age-dependent changes of hyaluronan in human skin. J Invest Dermatol 1994;102:385-9.
27. Kim JE, Sykes JM. Hyaluronic acid fillers: history and overview. Facial Plast Surg 2011;27:523-8.
28. Hinderer UT. Malar implants for improvement of the facial appearance. Plast Reconstr Surg 1975;56:157-65.
29. Oranges CM, Gohritz A, Haug M, Harder Y, Schaefer DJ. Universal and ethnic-specific considerations on facial rejuvenation: where do you inject your fillers? Plast Reconstr Surg Glob Open 2016;4:e842.
30. Maio M, DeBoulle K, Braz A, Rohrich RJ; Alliance for the Future of Aesthetics Consensus Committee. Facial assessment and injection guide for botulinum toxin and injectable hyaluronic acid fillers: focus on the midface. Plast Reconstr Surg 2017;140:540e-50e.
31. Raspaldo H, Gassia V, Niforos FR, Michaud T. Global, 3-dimensional approach to natural rejuvenation: part 1 - recommendations for volume restoration and the periocular area. J Cosmet Dermatol 2012;11:279-89.
32. Arsiwala SZ. Simplifying injectables for volumetric rejuvenation of face. J Cutan Aesthet Surg 2018;11:51-9.
33. Salti G, Rauso R. Facial rejuvenation with fillers: the dual plane technique. J Cutan Aesthet Surg 2015;8:127-33.
34. Tan M, Kontis TC. Midface volumization with injectable fillers. Facial Plast Surg Clin North Am 2015;23:233-42.
35. Weiss RA, Moradi A, Bank D, et al. Effectiveness and safety of large gel particle hyaluronic acid with lidocaine for correction of midface volume deficit or contour deficiency. Dermatol Surg 2016;42:699-709.
36. Monheit G, Kaufman-Janette J, Joseph JH, Shamban A, Dover JS, Smith S. Efficacy and safety of two resilient hyaluronic acid fillers in the treatment of moderate-to-severenasolabial folds: a 64-week, prospective, multicenter, controlled, randomized, double-blinded, and within-subject study. Dermatol Surg 2020;46:1521-9.
37. Jones D, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study. Dermatol Surg 2013;39:1602-12.
38. Few J, Cox SE, Paradkar-Mitragotri D, Murphy DK. A multicenter, single-blind randomized, controlled study of a volumizing hyaluronic acid filler for midface volume deficit: patient-reported outcomes at 2 years. Aesthet Surg J 2015;35:589-99.
39. Kerscher M, Agsten K, Kravtsov M, Prager W. Effectiveness evaluation of two volumizing hyaluronic acid dermal fillers in a controlled, randomized, double-blind, split-face clinical study. Clin Cosmet Investig Dermatol 2017;10:239-47.
40. Prager W, Agsten K, Kerscher M. Patient-reported outcomes following split-face injection of 2 volumizing fillers in the upper cheeks. Plast Reconstr Surg Glob Open 2017;5:e1412.
42. Jacovella PF. Use of calcium hydroxylapatite (Radiesse®) for facial augmentation. Clin Interv Aging 2008;3:161-74.
43. Marmur ES, Phelps R, Goldberg DJ. Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther 2004;6:223-6.
44. Yutskovskaya Y, Kogan E, Leshunov E. A randomized, split-face, histomorphologic study comparing a volumetric calcium hydroxylapatite and a hyaluronic acid-based dermal filler. J Drugs Dermatol JDD 2014;13:1047-52.
45. Berlin AL, Hussain M, Goldberg DJ. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg 2008;34 Suppl 1:S64-7.
46. Berri N, Fares J, Fares Y. Polyethylene oxide and silicon-substituted hydroxyapatite composite: a biomaterial for hard tissue engineering in orthopedic and spine surgery. Adv Biomed Res 2018;7:117.
47. Pajor K, Pajchel L, Kolmas J. Hydroxyapatite and fluorapatite in conservative dentistry and oral implantology-a review. Materials (Basel) 2019;12:2683.
48. Cohen JT, Benyamini L. Voice outcome after vocal fold injection augmentation with carboxymethyl cellulose versus calcium hydroxyapatite. J Laryngol Otol 2020;134:263-9.
49. Graivier MH, Bass LS, Busso M, Jasin ME, Narins RS, Tzikas TL. Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: consensus recommendations. Plast Reconstr Surg 2007;120:55S-66S.
50. Jansen DA, Graivier MH. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. Plast Reconstr Surg 2006;118:22S-30S, discussion 31S-3S.
51. Fitzgerald R, Carqueville J, Yang PT. An approach to structural facial rejuvenation with fillers in women. Int J Womens Dermatol 2019;5:52-67.
53. Loghem JV, Yutskovskaya YA, Werschler WP. Calcium hydroxylapatite: over a decade of clinical experience. J Clin Aesthetic Dermatol 2015;8:38.
54. Smith S, Busso M, McClaren M, Bass LS. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds. Dermatol Surg 2007;33 Suppl 2:S112-21; discussion S121.
55. Sadick NS, Katz BE, Roy D. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face. Dermatol Surg 2007;33 Suppl 2:S122-6; discussion S126-7.
56. Bass LS, Smith S, Busso M, McClaren M. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J 2010;30:235-8.
57. Rayess HM, Svider PF, Hanba C, et al. A cross-sectional analysis of adverse events and litigation for injectable fillers. JAMA Facial Plast Surg 2018;20:207-14.
58. Sickles CK, Nassereddin A, Gross GP. Poly-L-lactic acid. In: StatPearls. StatPearls Publishing; 2020.
59. Cabral LRB, Teixeira LN, Gimenez RP, et al. Effect of hyaluronic acid and poly-L-lactic acid dermal fillers on collagen synthesis: an in vitro and in vivo Study. Clin Cosmet Investig Dermatol 2020;13:701-10.
60. Rotunda AM, Narins RS. Poly-L-lactic acid: a new dimension in soft tissue augmentation. Dermatol Ther 2006;19:151-8.
61. Galderma. Sculptra aesthetic injectable poly-L-lactic acid. 2020. Available from: https://www.galderma.com/us/site-s/g/files/jcdfhc341/files/2020-11/782347%20Sculptra%20Aesthetic%20IFU.pdf. [Last accessed on 2 Aug 2020].
62. Vleggaar D, Fitzgerald R, Lorenc ZP, et al. Consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization. J Drugs Dermatol JDD 2014;13:s44-51.
63. Bartus C, William Hanke C, Daro-Kaftan E. A decade of experience with injectable poly-L-lactic acid: a focus on safety. Dermatol Surg 2013;39:698-705.
64. Lowe NJ, Maxwell CA, Lowe P, Shah A, Patnaik R. Injectable poly-l-lactic acid: 3 years of aesthetic experience. Dermatol Surg 2009;35 Suppl 1:344-9.
65. Bauer U, Graivier MH. Optimizing injectable poly-L-lactic acid administration for soft tissue augmentation: the rationale for three treatment sessions. Can J Plast Surg J Can Chir Plast 2011;19:e22-7.
66. Butterwick K, Lowe NJ. Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience. J Am Acad Dermatol 2009;61:281-93.
67. Salles AG, Lotierzo PH, Gimenez R, Camargo CP, Ferreira MC. Evaluation of the poly-L-lactic acid implant for treatment of the nasolabial fold: 3-year follow-up evaluation. Aesthetic Plast Surg 2008;32:753-6.
68. Narins RS, Baumann L, Brandt FS, et al. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol 2010;62:448-62.
69. Brandt FS, Cazzaniga A, Baumann L, et al. Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles. Aesthet Surg J 2011;31:521-8.
70. Brown SA, Rohrich RJ, Baumann L, et al. Subject global evaluation and subject satisfaction using injectable poly-L-lactic acid versus human collagen for the correction of nasolabial fold wrinkles. Plast Reconstr Surg 2011;127:1684-92.
71. Hyun MY, Lee Y, No YA, et al. Efficacy and safety of injection with poly-L-lactic acid compared with hyaluronic acid for correction of nasolabial fold: a randomized, evaluator-blinded, comparative study. Clin Exp Dermatol 2015;40:129-35.
72. Narins RS. Minimizing adverse events associated with poly-L-lactic acid injection. Dermatol Surg 2008;34 Suppl 1:S100-4.
73. Haneke E. Managing complications of fillers: rare and not-so-rare. J Cutan Aesthet Surg 2015;8:198-210.
74. Solomon P, Sklar M, Zener R. Facial soft tissue augmentation with Artecoll®: A review of eight years of clinical experience in 153 patients. Can J Plast Surg 2012;20:28-32.
75. Morhenn VB, Lemperle G, Gallo RL. Phagocytosis of different particulate dermal filler substances by human macrophages and skin cells. Dermatol Surg 2002;28:484-90.
76. Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 2003;29:573-87; discussion 587.
77. Elson ML. The role of skin testing in the use of collagen injectable materials. J Dermatol Surg Oncol 1989;15:301-3.
78. Cohen SR, Holmes RE. Artecoll: a long-lasting injectable wrinkle filler material: report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg 2004;114:964-76; discussion 977-9.
79. Gold MH, Sadick NS. Optimizing outcomes with polymethylmethacrylate fillers. J Cosmet Dermatol 2018;17:298-304.
80. Salles AG, Lotierzo PH, Gemperli R, et al. Complications after polymethylmethacrylate injections: report of 32 cases. Plast Reconstr Surg 2008;121:1811-20.
81. Cohen S, Dover J, Monheit G, et al. Five-year safety and satisfaction study of PMMA-collagen in the correction of nasolabial folds. Dermatol Surg 2015;41 Suppl 1:S302-13.
82. Limongi RM, Tao J, Borba A, et al. Complications and management of polymethylmethacrylate (PMMA) injections to the midface. Aesthet Surg J 2016;36:132-5.
83. Keller G, Quatela VC, Antunes MB, Sykes JM, Magill CK, Seth R. Midface lift: panel discussion. Facial Plast Surg Clin North Am 2014;22:119-37.
84. Jacono AA, Malone MH, Lavin TJ. Nonsurgical facial rejuvenation procedures in patients under 50 prior to undergoing facelift: habits, costs, and results. Aesthet Surg J 2017;37:448-53.
85. Ransom ER, Stong BC, Jacono AA. Persistent improvement in lower eyelid-cheek contour after a transtemporal midface lift. Aesthetic Plast Surg 2012;36:1277-82.
86. Pascali M, Quarato D, Bocchini I, Cervelli V. Midface-lift patient satisfaction: a 5-year follow-up study. Indian J Plast Surg 2016;49:329-35.
87. Shtraks JP, Fundakowski C, Yu D, et al. Investigation of the longevity of the endoscopic midface lift. JAMA Facial Plast Surg 2019;21:535-41.
88. Pontius AT, Chaiet SR, Williams EF 3rd. Midface injectable fillers: have they replaced midface surgery? Facial Plast Surg Clin North Am 2013;21:229-39.
89. Hufschmidt K, Bronsard N, Foissac R, et al. The infraorbital artery: clinical relevance in esthetic medicine and identification of danger zones of the midface. J Plast Reconstr Aesthet Surg 2019;72:131-6.
90. Khan TT, Colon-Acevedo B, Mettu P, DeLorenzi C, Woodward JA. An anatomical analysis of the supratrochlear artery: considerations in facial filler iInjections and preventing vision loss. Aesthet Surg J 2017;37:203-8.
91. Gatherwright JR, Brown MS, Katira KM, Rowe DJ. Three-dimensional changes in the midface following malar calcium hydroxyapatite injection in a cadaver model. Aesthet Surg J 2015;35:NP169-75.
92. Casabona G. Blood Aspiration Test for cosmetic fillers to prevent accidental intravascular injection in the face. Dermatol Surg 2015;41:841-7.
93. Hojjat H, Raad R, Lucas J, et al. Public perception of facial fillers. Facial Plast Surg 2019;35:204-9.
94. DeLorenzi C. Complications of injectable fillers, part 2: vascular complications. Aesthet Surg J 2014;34:584-600.
95. Sito G, Manzoni V, Sommariva R. Vascular complications after facial filler injection: a literature review and meta-analysis. J Clin Aesthetic Dermatol 2019;12:E65-72.
96. Beleznay K, Carruthers JD, Humphrey S, Jones D. Avoiding and treating blindness from fillers: a review of the world literature. Dermatol Surg 2015;41:1097-117.
97. Biskupiak J, Sclafani AP. Economic analysis of "liquid" versus surgical face-lift: are large-volume facial soft tissue filler injection treatments a viable alternative to rhytidectomy? Facial Plast Surg 2010;26:296-302.
98. Kaufman-Janette J, Taylor SC, Cox SE, Weinkle SH, Smith S, Kinney BM. Efficacy and safety of a new resilient hyaluronic acid dermal filler, in the correction of moderate-to-severe nasolabial folds: a 64-week, prospective, multicenter, controlled, randomized, double-blind and within-subject study. J Cosmet Dermatol 2019;18:1244-53.
99. Food and Drug Administration: Summary of safety and effectiveness data (SSED). Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170002B.pdf. [Last accessed on 8 Aug 2021].
100. Rzany B, Converset-Viethel S, Hartmann M, et al. Efficacy and safety of 3 new resilient hyaluronic acid fillers, crosslinked with decreased BDDE, for the treatment of dynamic wrinkles: results of an 18-month, randomized controlled trial versus already available comparators. Dermatol Surg 2019;45:1304-14.
101. Niforos F, Ogilvie P, Cavallini M, et al. VYC-12 injectable gel is safe and effective for improvement of facial skin topography: a prospective study. Clin Cosmet Investig Dermatol 2019;12:791-8.
